These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1234 related items for PubMed ID: 12635465

  • 1. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.
    Attarbaschi A, Mann G, Dworzak M, Trebo M, Urban C, Fink FM, Horcher E, Reiter A, Riehm H, Gadner H, Austrian Cooperative Study Group.
    Wien Klin Wochenschr; 2002 Dec 30; 114(23-24):978-86. PubMed ID: 12635465
    [Abstract] [Full Text] [Related]

  • 2. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
    Salzburg J, Burkhardt B, Zimmermann M, Wachowski O, Woessmann W, Oschlies I, Klapper W, Wacker HH, Ludwig WD, Niggli F, Mann G, Gadner H, Riehm H, Schrappe M, Reiter A.
    J Clin Oncol; 2007 Sep 01; 25(25):3915-22. PubMed ID: 17761975
    [Abstract] [Full Text] [Related]

  • 3. Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster Group.
    Seidemann K, Tiemann M, Lauterbach I, Mann G, Simonitsch I, Stankewitz K, Schrappe M, Zimmermann M, Niemeyer C, Parwaresch R, Riehm H, Reiter A, NHL Berlin-Frankfurt-Münster Group.
    J Clin Oncol; 2003 May 01; 21(9):1782-9. PubMed ID: 12721255
    [Abstract] [Full Text] [Related]

  • 4. [NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphoma in children and adolescents. Part 3: An intermediate term analysis of the B-NHL/B-ALL].
    Reiter A, Schrappe M, Yakisan E, Sauter S, Ebell W, Zimmermann M, Hartmann W, Kremens B, Kuhn N, Claviez A.
    Klin Padiatr; 1994 May 01; 206(4):242-52. PubMed ID: 7967420
    [Abstract] [Full Text] [Related]

  • 5. Improved treatment outcome in Chinese children and adolescents with Burkitt's lymphoma and large cell lymphoma by using the modified B-non-Hodgkin's lymphoma-Berlin-Frankfurt-Münster-90 protocol.
    Sun XF, Zhen ZJ, Lui DG, Xia Y, He YJ, Wang ZH, Lin JY, Guan ZZ.
    Eur J Haematol; 2006 Nov 01; 77(5):365-71. PubMed ID: 16879606
    [Abstract] [Full Text] [Related]

  • 6. Outcome of children with primary resistant or relapsed non-Hodgkin lymphoma and mature B-cell leukemia after intensive first-line treatment: a population-based analysis of the Austrian Cooperative Study Group.
    Attarbaschi A, Dworzak M, Steiner M, Urban C, Fink FM, Reiter A, Gadner H, Mann G.
    Pediatr Blood Cancer; 2005 Jan 01; 44(1):70-6. PubMed ID: 15368550
    [Abstract] [Full Text] [Related]

  • 7. [NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphomas in children and adolescents. Part 1: Classification and allocation to strategic therapy groups. BIF study group].
    Reiter A, Tiemann M, Ludwig WD, Wacker HH, Yakisan E, Schrappe M, Henzler D, Sykora KW, Brandt A, Odenwald E.
    Klin Padiatr; 1994 Jan 01; 206(4):222-33. PubMed ID: 7967418
    [Abstract] [Full Text] [Related]

  • 8. [The treatment results in children diagnosed with non-Hodgkin's lymphomas and acute B-cell lymphoblastic leukemias treated by the BFM protocols. The report of the POGM (Pediatric Oncology Group of Madrid)].
    Vivanco Martínez JL, López Pérez J, Melero Moreno C, Torres Valdivieso MJ, Palacios López ME, Contra Gómez T, Martín Ramos N, Bernacer Borja M, Gil López C, Valverde Moreno F.
    An Esp Pediatr; 1998 Dec 01; 49(6):603-8. PubMed ID: 9972623
    [Abstract] [Full Text] [Related]

  • 9. Treatment of children and adolescents with non-Hodgkin's lymphoma (results based on the NHL Berlin-Frankfurt-Münster 90 protocols).
    Kavan P, Kabicková E, Gajdos P, Koutecký J, Smelhaus V, Stanková J, McClain KL.
    Cas Lek Cesk; 1999 Jan 18; 138(2):40-6. PubMed ID: 10376402
    [Abstract] [Full Text] [Related]

  • 10. [Hungarian experience with non-Hodgkin's lymphoma in childhood].
    Müller J, Csóka M, Jakab Z, Ponyi A, Erlaky H, Kovács G.
    Magy Onkol; 2006 Jan 18; 50(3):253-9. PubMed ID: 17099787
    [Abstract] [Full Text] [Related]

  • 11. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
    Sun XF, Su YS, Liu DG, Jiang WQ, He YJ, Lin TY, Huang HQ, Zhang L, Xia ZJ, Li YH, Zhou ZM, Chen XQ, Xia Y, Zhen ZJ, Guan ZZ.
    Ai Zheng; 2004 Aug 18; 23(8):933-8. PubMed ID: 15301718
    [Abstract] [Full Text] [Related]

  • 12. Treatment results of childhood acute lymphoblastic leukemia in Austria--a report of 20 years' experience.
    Attarbaschi A, Mann G, Dworzak M, Urban C, Fink FM, Dieckmann K, Riehm H, Gadner H, Austrian Cooperative Study Group.
    Wien Klin Wochenschr; 2002 Feb 28; 114(4):148-57. PubMed ID: 12060981
    [Abstract] [Full Text] [Related]

  • 13. Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Münster Trial NHL-BFM 95.
    Seidemann K, Zimmermann M, Book M, Meyer U, Burkhardt B, Welte K, Reiter A, Stanulla M.
    J Clin Oncol; 2005 Nov 20; 23(33):8414-21. PubMed ID: 16293872
    [Abstract] [Full Text] [Related]

  • 14. The role of initial laparotomy and second-look surgery in the treatment of abdominal B-cell non-Hodgkin's lymphoma of childhood. A report of the BFM Group.
    Reiter A, Zimmermann W, Zimmermann M, von Schweinitz D, Riehm H, Mildenberger H.
    Eur J Pediatr Surg; 1994 Apr 20; 4(2):74-81. PubMed ID: 8025100
    [Abstract] [Full Text] [Related]

  • 15. The influence of maximum supportive care on dose compliance and survival. Single-center analysis of childhood acute lymphoblastic leukemia and non-Hodgkin's-lymphoma treated within 1984-1993.
    Urban C, Benesch M, Lackner H, Schwinger W, Kerbl R, Gadner H.
    Klin Padiatr; 1997 Apr 20; 209(4):235-42. PubMed ID: 9293456
    [Abstract] [Full Text] [Related]

  • 16. [Progress in the treatment of non-Hodgkin's lymphoma (NHL) in children. The report of Polish Pediatric Leukaemia/lymphoma Study Group (PPLLSG)].
    Wróbel G, Kazanowska B, Chybicka A, Jeleń M, Małdyk J, Sowińska E, Balcerska A, Balwierz W, Bubała H, Kołakowska-Mrozowska B, Kołtan A, Korzon M, Kowalczyk J, Krawczuk-Rybak M, Maciejka-Kapuścińska L, Matysiak M, Płoszyńska A, Popadiuk S, Solarz E, Sońta-Jakimczyk D, Sopyło B, Stańczak E, Stefaniak J, Stefańska K, Wachowiak J, Wieczorek M, Wysocki M.
    Przegl Lek; 2004 Apr 20; 61 Suppl 2():45-8. PubMed ID: 15686045
    [Abstract] [Full Text] [Related]

  • 17. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
    Reiter A, Schrappe M, Parwaresch R, Henze G, Müller-Weihrich S, Sauter S, Sykora KW, Ludwig WD, Gadner H, Riehm H.
    J Clin Oncol; 1995 Feb 20; 13(2):359-72. PubMed ID: 7844597
    [Abstract] [Full Text] [Related]

  • 18. [Comparison of the efficacy of CCCG-97 and BFM-90 protocols in the treatment for children with mature B-cell non-Hodgkin's lymphoma].
    Meng JH, Gao YJ, Lu FJ, Zhai XW, Wang HS, Li J.
    Zhonghua Zhong Liu Za Zhi; 2012 Mar 20; 34(3):222-7. PubMed ID: 22780979
    [Abstract] [Full Text] [Related]

  • 19. Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.
    Einsiedel HG, von Stackelberg A, Hartmann R, Fengler R, Schrappe M, Janka-Schaub G, Mann G, Hählen K, Göbel U, Klingebiel T, Ludwig WD, Henze G.
    J Clin Oncol; 2005 Nov 01; 23(31):7942-50. PubMed ID: 16258094
    [Abstract] [Full Text] [Related]

  • 20. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A, Mann G, Panzer-Grümayer R, Röttgers S, Steiner M, König M, Csinady E, Dworzak MN, Seidel M, Janousek D, Möricke A, Reichelt C, Harbott J, Schrappe M, Gadner H, Haas OA.
    J Clin Oncol; 2008 Jun 20; 26(18):3046-50. PubMed ID: 18565891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.